Dechra Pharmaceuticals
DPH.L
#2523
Rank
A$8.96 B
Marketcap
$78.72
Share price
0.05%
Change (1 day)
67.92%
Change (1 year)

Revenue for Dechra Pharmaceuticals (DPH.L)

Revenue in 2023: A$1.53 Billion

According to Dechra Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is A$1.53 Billion. In 2023 the company made a revenue of A$1.53 Billion an increase over the revenue in the year 2022 that were of A$1.32 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dechra Pharmaceuticals from 1998 to 2023

Annual revenue

Year Revenue Change
2023A$1.53 B16.13%
2022A$1.32 B-1.72%
2021A$1.34 B32.73%
2020A$1.01 B3.68%
2019A$0.97 B13.75%
2018A$0.86 B15.02%
2017A$0.74 B40.23%
2016A$0.53 B4.14%
2015A$0.51 B-2.92%
2014A$0.52 B14.63%
2013A$0.46 B-56.95%
2012A$1.07 B6.77%
2011A$1.00 B13.36%
2010A$0.88 B-4.21%
2009A$0.92 B-5%
2008A$0.97 B18.45%
2007A$0.82 B19.14%
2006A$0.68 B14.19%
2005A$0.60 B10.69%
2004A$0.54 B10.36%
2003A$0.49 B43.26%
2002A$0.34 B8.82%
2001A$0.31 B7.5%
2000A$0.29 B11.26%
1999A$0.26 B6.42%
1998A$0.24 B